GENERAL ATLANTIC L.P. 13D and 13G filings for CinCor Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-28 4:16 pm Sale | 2023-02-24 | 13D | CinCor Pharma, Inc. CINC | GENERAL ATLANTIC L.P. | 0 0.000% | -4,209,470 (Position Closed) | Filing |
| 2023-01-11 3:01 pm Purchase | 2023-01-09 | 13D | CinCor Pharma, Inc. CINC | GENERAL ATLANTIC L.P. | 4,209,470 9.600% | 83,000 (+2.01%) | Filing |
| 2022-01-21 1:07 pm Purchase | 2022-01-11 | 13D | CinCor Pharma, Inc. CINC | GENERAL ATLANTIC L.P. | 4,126,470 11.300% | 4,126,470 (New Position) | Filing |